Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Laser Photonics (LASE) Shares Outstanding (Weighted Average) (2019 - 2025)

Laser Photonics (LASE) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 77.58% to $2.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Sep 2025, down 77.58% year-over-year, with the annual reading at $11.6 million for FY2024, 6362.22% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $2.4 million in Q3 2025 for Laser Photonics, down from $14.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $14.3 million in Q2 2025 to a low of $180000.0 in Q2 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $6.4 million across 5 years, with a median of $4.9 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 92.83% in 2023 and later soared 7829.93% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $4.9 million in 2021, then rose by 16.58% to $5.7 million in 2022, then surged by 57.09% to $8.9 million in 2023, then surged by 30.2% to $11.6 million in 2024, then plummeted by 79.09% to $2.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for LASE at $2.4 million in Q3 2025, $14.3 million in Q2 2025, and $14.3 million in Q1 2025.